Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Let the game begin.
Uplist and asco the coming weeks a new floor is coming ahead
Gl and congrats to all
short term, yes.
it should be interesting when YHOO consolidates.
keep an eye on the interim ceo and Loeb. should see a game plan coming together prior to the next quarter.
enjoy!
reverse split is inevitable.
the next quarter should bare some light on this possibility.
gl
big mistake with the interim title. the candidate is impressive and may be the right person for the right time.
should have been made the ceo, with out "interim"
but do like the interemediate outlook. especially with Loeb involved in the the decision making. ( though the relationship may be prickly)
gl
not sure about no risk, but should happy with the six month chart at the end of the year.
gl
odd trading the last few days.
gl
better than everage volume.
gl
i do agree with your sentiment.
still holding, but dissapointed with how things have played out, but they have tried to carry this company professionally.
unfortunately, dilution is revenue untill they generate it on the business side.
gl, and good to see some old faces!
First quarter financials out.
fairly even. which is typically is poor, but for a developmental company pretty good.
gl
Look for MSFT to be back in play
Gl
Loeb factor in play!
"Blood in the streets"
Entry point?
Gl
Ebix Inc (EBIX) filed Quarterly Report for the period ended 2012-03-31.
Ebix Inc has a market cap of $765 million; its shares were traded at around $18.67 with a P/E ratio of 12.7 and P/S ratio of 4.5. The dividend yield of Ebix Inc stocks is 0.8%. Ebix Inc had an annual average earning growth of 53% over the past 10 years.
http://www.gurufocus.com/news/175908/ebix-inc-reports-operating-results-10q
look for a run up prior to the next quarterly release!
gl
for those who dont look beyond the pps.
10-q
http://biz.yahoo.com/e/120511/imuc.ob10-q.html
gl
Probably have to wait for the next quarterly report for conclusive data. But trend the other companies with imuc
Short term is going to be volatile with positive gains. As the long term play is a no brainer
Gl
Short term up and downs will likely be parlayed by mentor capital.
Just sn observation but swings have been consistent with there portfolio
http://www.marketwatch.com/story/mentor-capital-cancer-immunotherapy-index-gains-47-during-first-quarter-2012-04-17
Gl
Your too funny!
Enjoyable rollercoaster!
Gl
The company is ahead of the curve
30 is a reasonable. Short term target
But for perspective I re bought back in 22 dollar range
Gl
I agree, competition will evolve.
Juan success will go and fail with apple untill they expand the dragon market and upgrade the technology.
Competition will be formidable soon…not now
Gl
not accurate and misleading...several people have spoken to OTC markets (myself) and this issue is mainly due to delay in the financials being posted. nothing else.
gl
one of my favorites.
this stock was one my favorite ipo.
6months to year, we will likely be very happy with this investmant.
gl
excellent link, thank you for sharing.
patience will pay of here!
gl all
this stock is reminding me of ECYT. grinding through the shares twds the ineveitable catalyst for the upcoming weeks!
everyone patience will be tested.
gl all
Spinning, no.....
A small stake at $5. (Was waiting for the biomedreport crowd to sell off), and the $4 range offered good support.
The potential is huge, and finally they are beginning to unfold there plan.
Right now its all about the data!
Gl. And hope it takes more for your head to spin!
eyes wide open!
gl all!
speculation is over.
next step is to gain medicare coverage state by state which will be an uphill battle and build a patient base.
gl
a good entry?
my opinion, yes.
gl
probably will see steady growth and a good outlook from here on.
it has become a true holding for an investor.
gl
IMUC is trading fairly tightly, and is pretty wound up!
should be interesting to see it when volume hits the shores.
gl
next few weeks will be critical for ILMN boared.
institutional ownership (the ones not selling) will be looking for support in $42.
gl all
excellent day, a lot earlier than i expected.
nice little suprise tyhis am!
gl all
190,000 shares at $2.74
interesting day?
low volume day, private sale?
gl
?
low volume decline would not be considered "rocked"
gl
Correct me if i'm wrong but april 12 would be the 30th trading day above $2.
gl
its not about the WAG, its about your decision to invest or to trade....in the big picture its all the same.
that decision will always be yours.
nothing wrong with either but just do whats best for you!
gl
50(MA) is the most important indicator for the short term.
long term potential is as solid as the PDUFA, but the only question is the re-entry?
gl
its only a possibility if your a charting the graph and taking out all variables.
but agree as i said, there are way too many catalysts in play where it would be dangerous.
gl
Looking at the burn rate....
Thinking out loud.
Gl
looking it as a pure trader, imuc just broke against the bullish trend looking at the next support at $2.52.
after stating that, this biotech has several catlysts that have been listed by several members during coming 4-6 weeks, suggesting that chart playing can be dangerous.
though profit is profit.
true question that needs to addressed is the cash value, and does it have the 4 million dollar equity to get listed for amex. (As i believe it has the cash).
The company has methodically orchestrated a story, and the stock continues to have strong postive sentiment on its side, for now.
Long on this one!
another footnote, below is a link from a person on the ICT trial.
feel good story.
http://glioblasted.wordpress.com/category/treatments/
2 excerpts:
1. The MRI from my March 19, 2012, Cycle 4 appointment at UAB revealed no tumor recurrence. The cavity in my brain looks good.
Tina breathed a big sigh of relief.
I was unfazed. I mean, I was glad to hear the good news, but was not surprised at all. We then drove three hours back to Atlanta.
Upon returning home, I was immediately overcome with fatigue, collapsed into bed and slept heavily for several hours. Now this was a surprise to me because I’ve been getting plenty of sleep, including the night before. I suspect that while I consciously don’t feel any sense of anxiety or fear about the cancer manifesting as a deadly tumor, I might unconsciously carry it as an exhausting burden. Maybe hearing the good news allowed me to release a tension of which I was not aware.
In any case, I feel great now.
2. The transfer from Chicago to Birmingham is complete. I’m officially participating in the ICT-107 clinical trial at the Kirklin Center at UAB as of January 23, 2012. This visit concludes Cycle 2 of the Extended Maintenance Phase. I had an MRI. The images showed no tumor growth. Things look pretty good. I will continue with chemo. My weight is down to 160 pounds. Dosage for Cycle 3 is 400mg of Temodar
gl
fairly good "stand alone deal".
should be interesting too see the pps when the pressure and hoopla ends
gl